This Amer Sports Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - SM
Analysts initiated coverage on five companies: Goldman Sachs rated Abivax Buy with $155 PT, BTIG rated Amer Sports Buy with $42 PT, Morgan Stanley rated Coinbase Equal-Weight with $250 PT, Oppenheimer rated Aehr Test Outperform with $120 PT, and Piper Sandler rated Intel Neutral with $110 PT. All companies closed below their respective targets on Wednesday.
How this was made
The 30-second read
Why it matters
These initiations provide fresh analyst sentiment that could influence short‑term price action.
Market read
New coverage can prompt short‑term trading interest and modest price moves.
What to watch
Potential for rating revisions; price targets may be optimistic given current valuations.
Background
The article lists new analyst coverage initiations with ratings and price targets for five publicly traded companies.
Ticker impact
Goldman Sachs initiated coverage on Abivax with a Buy rating and $155 price target.
Potential modest upside as investors price in new coverage.
Buy rating and target above current price suggest upside.
BTIG initiated coverage on Amer Sports with a Buy rating and $42 price target.
Likely modest rally if market follows the rating.
Buy rating and target well above current price.
Morgan Stanley initiated coverage on Coinbase with an Equal-Weight rating and $250 price target.
Limited immediate move; price may test target over time.
Rating is not a clear buy/sell, target is high relative to price.
Oppenheimer initiated coverage on Aehr Test Systems with an Outperform rating and $120 price target.
Potential upside if investors act on the rating.
Target exceeds current price, indicating upside.
Piper Sandler initiated coverage on Intel with a Neutral rating and $110 price target.
Small move possible; price may stay near current levels.
Neutral stance and modest target relative to price.
Market effects
Analyst initiations may lift sentiment across the biotech, sports equipment, crypto, semiconductor test and chip sectors.
Primarily U.S. market impact as all firms are U.S.-listed.
Limited to investors tracking analyst coverage; no broad macro effect.
Counterpoint
Some investors may view fresh coverage as premature, especially for volatile crypto and micro‑cap stocks.
Key entities
- AnalystGoldman Sachs
Initiated coverage on ABVX.
- AnalystBTIG
Initiated coverage on AS.
- AnalystMorgan Stanley
Initiated coverage on COIN.
- AnalystOppenheimer
Initiated coverage on AEHR.
- AnalystPiper Sandler
Initiated coverage on INTC.
